Publications by authors named "Rudolf Fehrmann"

Claim this Profile
M
MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage.
Renske Linstra, Chantal Stappenbelt, Femke J Bakker, Marieke Everts, Arkajyoti Bhattacharya, Rudolf S N Fehrmann

J Biol Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer.
Arkajyoti Bhattacharya, Thijs S Stutvoet, Mirela Perla, Stefan Loipfinger, Mathilde Jalving, Rudolf S N Fehrmann

Elife· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin E1 overexpression triggers interferon signaling and is associated with antitumor immunity in breast cancer.
Shibo Yu, Chantal Stappenbelt, Mengting Chen, Mirte Dekker, Arkajyoti Bhattacharya, Rudolf S N Fehrmann

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional ex vivo DNA fibre assay to measure replication dynamics in breast cancer tissue.
Mengting Chen, Nathalie van den Tempel, Arkajyoti Bhattacharya, Shibo Yu, Bea Rutgers, Rudolf Sn Fehrmann

J Pathol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer.
Madelon J H Metman, Pascal K C Jonker, Luc H J Sondorp, Bettien M van Hemel, Mark S Sywak, Rudolf S N Fehrmann

Eur J Nucl Med Mol Imaging· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential imaging targets in primary head and neck squamous cell carcinoma and lymph node metastases.
Jeroen E van Schaik, Bert van der Vegt, Lorian Slagter-Menkema, Saskia H Hanemaaijer, Gyorgi B Halmos, Rudolf S N Fehrmann

Am J Otolaryngol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer.
Daan G Knapen, Sara Hone Lopez, Derk Jan A de Groot, Jacco-Juri de Haan, Elisabeth G E de Vries, Rudolf S N Fehrmann

Commun Med (Lond)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of new head and neck squamous cell carcinoma molecular imaging targets.
Jeroen E van Schaik, Bert van der Vegt, Lorian Slagter-Menkema, Bernard F A M van der Laan, Max J H Witjes, Rudolf S N Fehrmann

Oral Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.
Johannes R Björk, Laura A Bolte, Andrew Maltez Thomas, Karla A Lee, Niccolo Rossi, Rudolf S N Fehrmann

Nat Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current state and prospects of artificial intelligence in allergy.
Merlijn van Breugel, Rudolf S N Fehrmann, Marnix Bügel, Faisal I Rezwan, John W Holloway

Allergy· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FIRRM/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics.
Colin Stok, Stavroula Tsaridou, Nathalie van den Tempel, Marieke Everts, Elles Wierenga, Rudolf S N Fehrmann

Cell Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma.
Laura A Bolte, Karla A Lee, Johannes R Björk, Emily R Leeming, Marjo J E Campmans-Kuijpers, Rudolf Fehrmann

JAMA Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.
Olivier J van Not, Thijs T Wind, Rawa K Ismail, Arkajyoti Bhattacharya, Mathilde Jalving, Rudolf S N Fehrmann

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities on the horizon for the management of early colon cancer.
Daan G Knapen, Jacco J de Haan, Rudolf S N Fehrmann, Elisabeth G E de Vries, Derk Jan A de Groot

Crit Rev Oncol Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma.
Alessia Visconti, Niccolò Rossi, Helena Deriš, Karla A Lee, Maja Hanić, Rudolf S N Fehrmann

BMC Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-body CD8 T cell visualization before and during cancer immunotherapy: a phase 1/2 trial.
Laura Kist de Ruijter, Pim P van de Donk, Jahlisa S Hooiveld-Noeken, Danique Giesen, Sjoerd G Elias, Rudolf S N Fehrmann

Nat Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling.
Dario Zimmerli, Chiara S Brambillasca, Francien Talens, Jinhyuk Bhin, Renske Linstra, Rudolf S N Fehrmann

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma.
Niccolò Rossi, Karla A Lee, Maria V Bermudez, Alessia Visconti, Andrew Maltez Thomas, Rudolf S N Fehrmann

EBioMedicine· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection.
Pascal K C Jonker, Madelon J H Metman, Luc H J Sondorp, Mark S Sywak, Anthony J Gill, Rudolf S N Fehrmann

Eur J Nucl Med Mol Imaging· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.
Sjoukje F Oosting, Astrid A M van der Veldt, Rudolf S N Fehrmann, Corine H GeurtsvanKessel, Rob S van Binnendijk

Lancet Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gut wall's potential as a partner for precision oncology in immune checkpoint treatment.
Sara Hone Lopez, Mathilde Jalving, Rudolf S N Fehrmann, Wouter B Nagengast, Elisabeth G E de Vries

Cancer Treat Rev· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation.
Christos E Zois, Anne M Hendriks, Syed Haider, Elisabete Pires, Esther Bridges, Rudolf S N Fehrmann

Cell Death Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Novel Molecular Imaging Targets Identified by Functional Genomic mRNA Profiling to Detect Dysplasia in Barrett's Esophagus.
Xiaojuan Zhao, Ruben Y Gabriëls, Wouter T R Hooghiemstra, Marjory Koller, Gert Jan Meersma, Rudolf S N Fehrmann

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma.
Karla A Lee, Andrew Maltez Thomas, Laura A Bolte, Johannes R Björk, Laura Kist de Ruijter, Rudolf S N Fehrmann

Nat Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An mRNA expression-based signature for oncogene-induced replication-stress.
Sergi Guerrero Llobet, Arkajyoti Bhattacharya, Marieke Everts, Klaas Kok, Bert van der Vegt, Rudolf S N Fehrmann

Oncogene· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis